Intellectual Property India Publishes Patent Application for 'Dosage Forms Of Tafamidis And Its Pharmaceutically Acceptable Salt Thereof' Filed by Biophore India Pharmaceuticals Pvt. Ltd.

MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202441035075 A) filed by Biophore India Pharmaceuticals Pvt. Ltd, Hyderabad, Telangana, on May 3, 2024, for 'dosage forms of tafamidis and its pharmaceutically acceptable salt thereof.'

Inventor(s) include Manik Reddy Pullagurla; Srinivas Arutla; and Jagadeesh Babu Rangisetty.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to a novel liquid dosage form comprising composition containing tafamidis or its pharmaceutically acceptable salt particularly tafamidis meglumine and process of preparation thereof. The disclosure also r...